BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25010895)

  • 1. Cell exhaustion in HIV-1 infection: role of suppressor cells.
    Seddiki N; Brezar V; Draenert R
    Curr Opin HIV AIDS; 2014 Sep; 9(5):452-8. PubMed ID: 25010895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T regulatory cells and HIV infection.
    Sempere JM; Soriano V; Benito JM
    AIDS Rev; 2007; 9(1):54-60. PubMed ID: 17474313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
    Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
    J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell exhaustion in HIV infection: the role of immune activation.
    Moir S; Fauci AS
    Curr Opin HIV AIDS; 2014 Sep; 9(5):472-7. PubMed ID: 25023621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.
    Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CM; Pett S; Ananworanich J; Zaunders J; Kelleher AD
    Eur J Immunol; 2014 Jun; 44(6):1644-61. PubMed ID: 24752698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring cellular immune markers in HIV infection: from activation to exhaustion.
    Sauce D; Elbim C; Appay V
    Curr Opin HIV AIDS; 2013 Mar; 8(2):125-31. PubMed ID: 23380653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells at the interface of innate and adaptive immunity to HIV-1.
    Smed-Sörensen A; Loré K
    Curr Opin HIV AIDS; 2011 Sep; 6(5):405-10. PubMed ID: 21743321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic pathways as regulators of HIV infection.
    Craveiro M; Clerc I; Sitbon M; Taylor N
    Curr Opin HIV AIDS; 2013 May; 8(3):182-9. PubMed ID: 23564003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection.
    Swaminathan S; Kelleher AD
    Curr Opin HIV AIDS; 2014 Sep; 9(5):464-71. PubMed ID: 25023625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting HIV-1 innate immune responses therapeutically.
    Ellegård R; Shankar EM; Larsson M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):435-43. PubMed ID: 21734566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine and immunotherapeutic interventions.
    Pantaleo G; Lévy Y
    Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption.
    González-Serna A; Abad-Fernández M; Soriano-Sarabia N; Leal M; Vallejo A
    J Clin Virol; 2013 Dec; 58(4):703-9. PubMed ID: 24210957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of HIV-1 and T-cell adaptive immunity: progress to date.
    Mohan T; Bhatnagar S; Gupta DL; Rao DN
    Microb Pathog; 2014 Aug; 73():60-9. PubMed ID: 24930593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Regulatory T Cells and Inhibitory Molecules in the Development of Immune Exhaustion During Human Immunodeficiency Virus Type 1 Infection.
    Gonzalez SM; Zapata W; Rugeles MT
    Viral Immunol; 2016; 29(1):2-10. PubMed ID: 26566019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells (Tregs): A major immune checkpoint to consider in combinatorial therapeutic HIV-1 vaccines.
    Hubert A; Seddiki N
    Hum Vaccin Immunother; 2018 Jun; 14(6):1432-1437. PubMed ID: 29381418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signatures of T-cell inhibition in HIV-1 infection.
    Larsson M; Shankar EM; Che KF; Saeidi A; Ellegård R; Barathan M; Velu V; Kamarulzaman A
    Retrovirology; 2013 Mar; 10():31. PubMed ID: 23514593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.